CN Stock MarketDetailed Quotes

603102 Weihai Baihe Biology Technological

Watchlist
  • 33.75
  • -0.25-0.74%
Market Closed Nov 15 15:00 CST
2.16BMarket Cap13.75P/E (TTM)

Weihai Baihe Biology Technological Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-4.14%606.33M
-8.04%411.88M
-18.68%188.64M
20.12%871.25M
21.82%632.51M
36.55%447.92M
58.73%231.97M
9.59%725.33M
10.47%519.22M
7.11%328.04M
Operating revenue
-4.14%606.33M
-8.04%411.88M
-18.68%188.64M
20.12%871.25M
21.82%632.51M
36.55%447.92M
58.73%231.97M
9.59%725.33M
10.47%519.22M
7.11%328.04M
Other operating revenue
----
7.66%2.36M
----
16.46%7M
----
-11.09%2.2M
----
-8.17%6.01M
----
7.94%2.47M
Total operating cost
-1.96%479.81M
-6.64%317.35M
-16.45%146.26M
21.27%686.86M
23.69%489.42M
38.64%339.94M
61.31%175.04M
12.57%566.38M
14.28%395.67M
5.69%245.2M
Operating cost
-2.10%376.26M
-8.39%249.21M
-19.87%112.9M
18.22%545.34M
18.42%384.34M
35.94%272.02M
65.58%140.89M
19.25%461.3M
27.24%324.56M
17.05%200.1M
Operating tax surcharges
-7.14%4.65M
-10.84%3.01M
-6.66%1.21M
29.95%6.63M
51.11%5.01M
42.56%3.38M
46.50%1.3M
0.19%5.1M
-18.26%3.31M
-12.55%2.37M
Operating expense
-6.74%57.79M
-1.92%39.02M
1.55%19.58M
39.45%79.81M
56.19%61.96M
57.89%39.78M
68.70%19.28M
1.48%57.23M
-14.41%39.67M
-16.96%25.19M
Administration expense
-2.80%27.01M
-2.85%18.39M
0.81%8.7M
11.10%39.16M
5.37%27.78M
21.22%18.93M
23.67%8.63M
13.61%35.25M
16.77%26.37M
1.63%15.62M
Financial expense
27.91%-8.55M
17.58%-6.94M
-92.86%-3.51M
-0.16%-15.03M
12.30%-11.86M
-4.43%-8.42M
-184.42%-1.82M
-5,479.71%-15.01M
-1,474.01%-13.52M
-5,411.05%-8.06M
-Interest expense (Financial expense)
----
----
-25.98%20.85K
-22.28%101.86K
----
----
--28.17K
--131.06K
----
----
-Interest Income (Financial expense)
9.55%-9.78M
8.29%-6.77M
-73.08%-3.5M
-69.61%-14.4M
-67.52%-10.81M
-113.37%-7.38M
-89.70%-2.02M
-689.86%-8.49M
-486.99%-6.45M
-456.71%-3.46M
Research and development
2.11%22.66M
2.97%14.67M
9.13%7.38M
37.51%30.95M
45.13%22.19M
42.75%14.24M
41.69%6.77M
-6.45%22.51M
-19.66%15.29M
-21.81%9.98M
Credit Impairment Loss
-76.42%-1.03M
-465.04%-927.6K
64.34%-560.74K
118.51%68.52K
20.41%-582.95K
54.79%-164.17K
-689.96%-1.57M
63.07%-370.25K
38.19%-732.49K
66.38%-363.13K
Asset Impairment Loss
11.32%-4.77M
-10.74%-4.79M
20.36%-4.08M
1.41%-5.55M
-13.25%-5.37M
-35.37%-4.33M
-69.84%-5.12M
-57.88%-5.63M
-98.84%-4.74M
-32.91%-3.2M
Other net revenue
47.84%6.45M
-90.32%438.96K
54.12%-2.52M
7,543.14%9.72M
1,098.02%4.36M
2,769.69%4.54M
-268.08%-5.49M
-97.66%127.2K
-107.78%-436.96K
-96.16%158.06K
Invest income
11.38%938.01K
24.07%591.44K
115.81%248.63K
161.23%1.11M
203.40%842.19K
274.29%476.71K
--115.21K
--423.08K
--277.59K
--127.36K
Asset deal income
----
----
----
-77.96%58.44K
-80.02%55.4K
4,704.86%22.32K
--12.58K
107,663.63%265.11K
--277.29K
--464.46
Other revenue
19.99%11.3M
-34.73%5.57M
73.81%1.87M
158.22%14.04M
110.01%9.42M
137.58%8.53M
-37.49%1.08M
-45.68%5.44M
-51.20%4.49M
-52.77%3.59M
Operating profit
-9.83%132.96M
-15.59%94.97M
-22.50%39.86M
22.03%194.11M
19.77%147.45M
35.57%112.51M
42.34%51.43M
-3.11%159.07M
-4.86%123.11M
5.88%82.99M
Add:Non operating Income
-48.83%825.18K
-58.33%186.13K
-94.78%16.49K
203.06%1.39M
482.17%1.61M
153.03%446.66K
648.52%315.63K
-93.22%458.08K
-95.85%277K
-85.73%176.53K
Less:Non operating expense
-75.17%381.2K
-90.42%77.43K
40.78%123.86K
59.56%2.08M
436.78%1.54M
188.97%808.24K
-54.38%87.98K
-18.55%1.3M
-69.49%286.02K
-53.16%279.7K
Total profit
-9.57%133.4M
-15.22%95.08M
-23.05%39.76M
22.24%193.42M
19.84%147.53M
35.30%112.15M
43.57%51.66M
-6.56%158.22M
-8.90%123.1M
4.89%82.89M
Less:Income tax cost
-11.07%16.74M
-17.56%12.11M
-28.68%4.91M
19.49%24.36M
14.38%18.82M
30.85%14.69M
40.90%6.88M
-4.27%20.38M
-4.22%16.46M
10.69%11.23M
Net profit
-9.35%116.67M
-14.87%82.97M
-22.18%34.85M
22.65%169.07M
20.68%128.7M
36.00%97.46M
43.99%44.78M
-6.89%137.84M
-9.59%106.65M
4.03%71.67M
Net profit from continuing operation
-9.35%116.67M
-14.87%82.97M
-22.18%34.85M
22.65%169.07M
20.23%128.7M
36.00%97.46M
43.99%44.78M
-6.89%137.84M
-9.25%107.05M
4.03%71.67M
Net income from discontinuing operating
----
----
----
----
----
----
----
----
---399.7K
----
Net profit of parent company owners
-9.35%116.67M
-14.87%82.97M
-22.18%34.85M
22.65%169.07M
20.68%128.7M
36.00%97.46M
43.99%44.78M
-6.89%137.84M
-9.59%106.65M
4.03%71.67M
Earning per share
Basic earning per share
-9.45%1.82
-14.47%1.3
-22.86%0.54
20.00%2.64
17.54%2.01
29.91%1.52
32.08%0.7
-28.57%2.2
-30.49%1.71
-18.75%1.17
Diluted earning per share
-9.45%1.82
-14.47%1.3
-22.86%0.54
20.00%2.64
17.54%2.01
29.91%1.52
32.08%0.7
-28.57%2.2
-30.49%1.71
-18.75%1.17
Other composite income
Total composite income
-9.35%116.67M
-14.87%82.97M
-22.18%34.85M
22.65%169.07M
20.68%128.7M
36.00%97.46M
43.99%44.78M
-6.89%137.84M
-9.59%106.65M
4.03%71.67M
Total composite income of parent company owners
-9.35%116.67M
-14.87%82.97M
-22.18%34.85M
22.65%169.07M
20.68%128.7M
36.00%97.46M
43.99%44.78M
-6.89%137.84M
-9.59%106.65M
4.03%71.67M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -4.14%606.33M-8.04%411.88M-18.68%188.64M20.12%871.25M21.82%632.51M36.55%447.92M58.73%231.97M9.59%725.33M10.47%519.22M7.11%328.04M
Operating revenue -4.14%606.33M-8.04%411.88M-18.68%188.64M20.12%871.25M21.82%632.51M36.55%447.92M58.73%231.97M9.59%725.33M10.47%519.22M7.11%328.04M
Other operating revenue ----7.66%2.36M----16.46%7M-----11.09%2.2M-----8.17%6.01M----7.94%2.47M
Total operating cost -1.96%479.81M-6.64%317.35M-16.45%146.26M21.27%686.86M23.69%489.42M38.64%339.94M61.31%175.04M12.57%566.38M14.28%395.67M5.69%245.2M
Operating cost -2.10%376.26M-8.39%249.21M-19.87%112.9M18.22%545.34M18.42%384.34M35.94%272.02M65.58%140.89M19.25%461.3M27.24%324.56M17.05%200.1M
Operating tax surcharges -7.14%4.65M-10.84%3.01M-6.66%1.21M29.95%6.63M51.11%5.01M42.56%3.38M46.50%1.3M0.19%5.1M-18.26%3.31M-12.55%2.37M
Operating expense -6.74%57.79M-1.92%39.02M1.55%19.58M39.45%79.81M56.19%61.96M57.89%39.78M68.70%19.28M1.48%57.23M-14.41%39.67M-16.96%25.19M
Administration expense -2.80%27.01M-2.85%18.39M0.81%8.7M11.10%39.16M5.37%27.78M21.22%18.93M23.67%8.63M13.61%35.25M16.77%26.37M1.63%15.62M
Financial expense 27.91%-8.55M17.58%-6.94M-92.86%-3.51M-0.16%-15.03M12.30%-11.86M-4.43%-8.42M-184.42%-1.82M-5,479.71%-15.01M-1,474.01%-13.52M-5,411.05%-8.06M
-Interest expense (Financial expense) ---------25.98%20.85K-22.28%101.86K----------28.17K--131.06K--------
-Interest Income (Financial expense) 9.55%-9.78M8.29%-6.77M-73.08%-3.5M-69.61%-14.4M-67.52%-10.81M-113.37%-7.38M-89.70%-2.02M-689.86%-8.49M-486.99%-6.45M-456.71%-3.46M
Research and development 2.11%22.66M2.97%14.67M9.13%7.38M37.51%30.95M45.13%22.19M42.75%14.24M41.69%6.77M-6.45%22.51M-19.66%15.29M-21.81%9.98M
Credit Impairment Loss -76.42%-1.03M-465.04%-927.6K64.34%-560.74K118.51%68.52K20.41%-582.95K54.79%-164.17K-689.96%-1.57M63.07%-370.25K38.19%-732.49K66.38%-363.13K
Asset Impairment Loss 11.32%-4.77M-10.74%-4.79M20.36%-4.08M1.41%-5.55M-13.25%-5.37M-35.37%-4.33M-69.84%-5.12M-57.88%-5.63M-98.84%-4.74M-32.91%-3.2M
Other net revenue 47.84%6.45M-90.32%438.96K54.12%-2.52M7,543.14%9.72M1,098.02%4.36M2,769.69%4.54M-268.08%-5.49M-97.66%127.2K-107.78%-436.96K-96.16%158.06K
Invest income 11.38%938.01K24.07%591.44K115.81%248.63K161.23%1.11M203.40%842.19K274.29%476.71K--115.21K--423.08K--277.59K--127.36K
Asset deal income -------------77.96%58.44K-80.02%55.4K4,704.86%22.32K--12.58K107,663.63%265.11K--277.29K--464.46
Other revenue 19.99%11.3M-34.73%5.57M73.81%1.87M158.22%14.04M110.01%9.42M137.58%8.53M-37.49%1.08M-45.68%5.44M-51.20%4.49M-52.77%3.59M
Operating profit -9.83%132.96M-15.59%94.97M-22.50%39.86M22.03%194.11M19.77%147.45M35.57%112.51M42.34%51.43M-3.11%159.07M-4.86%123.11M5.88%82.99M
Add:Non operating Income -48.83%825.18K-58.33%186.13K-94.78%16.49K203.06%1.39M482.17%1.61M153.03%446.66K648.52%315.63K-93.22%458.08K-95.85%277K-85.73%176.53K
Less:Non operating expense -75.17%381.2K-90.42%77.43K40.78%123.86K59.56%2.08M436.78%1.54M188.97%808.24K-54.38%87.98K-18.55%1.3M-69.49%286.02K-53.16%279.7K
Total profit -9.57%133.4M-15.22%95.08M-23.05%39.76M22.24%193.42M19.84%147.53M35.30%112.15M43.57%51.66M-6.56%158.22M-8.90%123.1M4.89%82.89M
Less:Income tax cost -11.07%16.74M-17.56%12.11M-28.68%4.91M19.49%24.36M14.38%18.82M30.85%14.69M40.90%6.88M-4.27%20.38M-4.22%16.46M10.69%11.23M
Net profit -9.35%116.67M-14.87%82.97M-22.18%34.85M22.65%169.07M20.68%128.7M36.00%97.46M43.99%44.78M-6.89%137.84M-9.59%106.65M4.03%71.67M
Net profit from continuing operation -9.35%116.67M-14.87%82.97M-22.18%34.85M22.65%169.07M20.23%128.7M36.00%97.46M43.99%44.78M-6.89%137.84M-9.25%107.05M4.03%71.67M
Net income from discontinuing operating -----------------------------------399.7K----
Net profit of parent company owners -9.35%116.67M-14.87%82.97M-22.18%34.85M22.65%169.07M20.68%128.7M36.00%97.46M43.99%44.78M-6.89%137.84M-9.59%106.65M4.03%71.67M
Earning per share
Basic earning per share -9.45%1.82-14.47%1.3-22.86%0.5420.00%2.6417.54%2.0129.91%1.5232.08%0.7-28.57%2.2-30.49%1.71-18.75%1.17
Diluted earning per share -9.45%1.82-14.47%1.3-22.86%0.5420.00%2.6417.54%2.0129.91%1.5232.08%0.7-28.57%2.2-30.49%1.71-18.75%1.17
Other composite income
Total composite income -9.35%116.67M-14.87%82.97M-22.18%34.85M22.65%169.07M20.68%128.7M36.00%97.46M43.99%44.78M-6.89%137.84M-9.59%106.65M4.03%71.67M
Total composite income of parent company owners -9.35%116.67M-14.87%82.97M-22.18%34.85M22.65%169.07M20.68%128.7M36.00%97.46M43.99%44.78M-6.89%137.84M-9.59%106.65M4.03%71.67M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data